These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23858026)

  • 1. Cilostazol strengthens the endothelial barrier of postcapillary venules from the rat mesentery in situ.
    Sugiura Y; Morikawa T; Takenouchi T; Suematsu M; Kajimura M
    Phlebology; 2014 Oct; 29(9):594-9. PubMed ID: 23858026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
    Aoki M; Morishita R; Hayashi S; Jo N; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Diabetologia; 2001 Aug; 44(8):1034-42. PubMed ID: 11484082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.
    Liu S; Yu C; Yang F; Paganini-Hill A; Fisher MJ
    J Neurol Sci; 2012 Sep; 320(1-2):45-51. PubMed ID: 22819056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol improves endothelial dysfunction by increasing endothelium-derived hyperpolarizing factor response in mesenteric arteries from Type 2 diabetic rats.
    Matsumoto T; Noguchi E; Ishida K; Nakayama N; Kobayashi T; Kamata K
    Eur J Pharmacol; 2008 Dec; 599(1-3):102-9. PubMed ID: 18930728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases.
    Wang J; Bingaman S; Huxley VH
    Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1146-54. PubMed ID: 20139324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct actions of endothelin-1 on single vessel hydraulic permeability.
    Victorino GP; Wisner DH; Tucker VL
    J Trauma; 1999 Oct; 47(4):713-8. PubMed ID: 10528606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules.
    Asako H; Kurose I; Wolf R; DeFrees S; Zheng ZL; Phillips ML; Paulson JC; Granger DN
    J Clin Invest; 1994 Apr; 93(4):1508-15. PubMed ID: 7512982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vascular effects of cilostazol.
    Weintraub WS
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):56B-60B. PubMed ID: 16498513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
    Nishio Y; Kashiwagi A; Takahara N; Hidaka H; Kikkawa R
    Horm Metab Res; 1997 Oct; 29(10):491-5. PubMed ID: 9405974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of cilostazol against retinal ischemic damage via inhibition of leukocyte-endothelial cell interactions.
    Iwama D; Miyamoto K; Miyahara S; Tamura H; Tsujikawa A; Yamashiro K; Kiryu J; Yoshimura N
    J Thromb Haemost; 2007 Apr; 5(4):818-25. PubMed ID: 17408412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
    Nakamura K; Ikomi F; Ohhashi T
    J Vasc Res; 2006; 43(1):86-94. PubMed ID: 16286783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of microvascular hydraulic permeability by platelet-activating factor.
    Victorino GP; Newton CR; Curran B
    J Trauma; 2004 Feb; 56(2):379-84. PubMed ID: 14960983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol protects diabetic rats from vascular inflammation via nuclear factor-kappa B-dependent down-regulation of vascular cell adhesion molecule-1 expression.
    Gao L; Wang F; Wang B; Gong B; Zhang J; Zhang X; Zhao J
    J Pharmacol Exp Ther; 2006 Jul; 318(1):53-8. PubMed ID: 16595735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microperfusion Technique to Investigate Regulation of Microvessel Permeability in Rat Mesentery.
    Curry FR; Clark JF; Adamson RH
    J Vis Exp; 2015 Sep; (103):. PubMed ID: 26436435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation.
    Schick MA; Wunder C; Wollborn J; Roewer N; Waschke J; Germer CT; Schlegel N
    J Physiol; 2012 Jun; 590(11):2693-708. PubMed ID: 22495586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cilostazol, a phosphodiesterase type III inhibitor, on histamine-induced increase in [Ca2+]i and force in middle cerebral artery of the rabbit.
    Shiraishi Y; Kanmura Y; Itoh T
    Br J Pharmacol; 1998 Mar; 123(5):869-78. PubMed ID: 9535015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
    Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
    Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol, a specific PDE-3 inhibitor, ameliorates chronic ileitis via suppression of interaction of platelets with monocytes.
    Matsunaga H; Hokari R; Higashiyama M; Kurihara C; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Miura S
    Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1077-84. PubMed ID: 19815627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol.
    Zhang Q; Huang JH; Xia RP; Duan XH; Jiang YB; Jiang Q; Sun WJ
    J Surg Res; 2011 May; 167(2):e385-93. PubMed ID: 21392796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.